International Journal of Cancer · 2003 · 82 citations · 13 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsMedical GeneticsMolecular OncologyCancer GenomicsGenetic Risk AssessmentGermline Cancer PredispositionGermline Cancer SusceptibilityMalignant NeoplasmsBrca MutationsCheckpointsChek2-related Cancer PredispositionFamilial Breast CancerFamilial Cancer RiskInherited Cancer Susceptibility
Searching for low-penetrance genes involved in breast cancer susceptibility has been a field of interest in the last few years. Recently, the CHEK 2 gene, involved in DNA damage and replication checkpoints, has been pointed out as a good candidate; moreover, a specific variant in this gene,1100delC, has been found to increase breast cancer susceptibility among familial breast cancer cases not attributable to mutations in BRCA1 or BRCA2 genes. In our present study, we evaluated the role of the 1100delC variant as a susceptibility allele in breast cancer in the Spanish population. However, our results suggest that this variant is absent or very infrequent in our population, making its screening irrelevant from the practical point of view.
13
Heterozygous Germ Line <i>hCHK2</i> Mutations in Li-Fraumeni Syndrome
Daphne W. Bell, Jennifer M. Varley, Tara E. Szydlo et al. · Science · 1999 · 902 citations
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Jong‐Soo Lee, Kimberly M. Collins, Alexandra L. Brown et al. · Nature · 2000 · 530 citations
Mutations in CHEK2 Associated with Prostate Cancer Risk
Xiangyang Dong, Liang Wang, Ken Taniguchi et al. · The American Journal of Human Genetics · 2003 · 305 citations · Full text